東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Biomarkers in inflammatory bowel dis...

Sheng Ding, Nik.

FindBook

Google Book

Amazon

博客來

Biomarkers in inflammatory bowel diseases

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Biomarkers in inflammatory bowel diseases/ edited by Nik Sheng Ding, Peter De Cruz.
其他作者:	Sheng Ding, Nik.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	xvii, 365 p. :ill. (some col.), digital ;24 cm.
內容註:	Part I: Introduction -- nflammatory bowel disease - more than meets the eye - Clinical risk factors - lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers - Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn's disease -- Luminal Crohn's disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn's disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.
Contained By:	Springer eBooks
標題:	Inflammatory bowel diseases - Molecular diagnosis. -
電子資源:	https://doi.org/10.1007/978-3-030-11446-6
ISBN:	9783030114466

Biomarkers in inflammatory bowel diseases
Biomarkers in inflammatory bowel diseases[electronic resource] /edited by Nik Sheng Ding, Peter De Cruz. - Cham :Springer International Publishing :2019. - xvii, 365 p. :ill. (some col.), digital ;24 cm.

Part I: Introduction -- nflammatory bowel disease - more than meets the eye - Clinical risk factors - lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers - Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn's disease -- Luminal Crohn's disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn's disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.

This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.

ISBN: 9783030114466

Standard No.: 10.1007/978-3-030-11446-6doiSubjects--Topical Terms:

3411137
Inflammatory bowel diseases
--Molecular diagnosis.

LC Class. No.: RC862.I53 / B566 2019

Dewey Class. No.: 616.344

Biomarkers in inflammatory bowel diseases
LDR:03250nmm a2200325 a 4500 001 2191613
003 DE-He213
005 20191106153219.0
006 m d
007 cr nn 008maaau
008 200504s2019 gw s 0 eng d
020 $a 9783030114466 $q (electronic bk.)
020 $a 9783030114459 $q (paper)
024 7 $a 10.1007/978-3-030-11446-6 $2 doi
035 $a 978-3-030-11446-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC862.I53 $b B566 2019
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJH $2 thema
082 0 4 $a 616.344 $2 23
090 $a RC862.I53 $b B615 2019
245 0 0 $a Biomarkers in inflammatory bowel diseases $h [electronic resource] / $c edited by Nik Sheng Ding, Peter De Cruz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xvii, 365 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I: Introduction -- nflammatory bowel disease - more than meets the eye - Clinical risk factors - lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers - Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn's disease -- Luminal Crohn's disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn's disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.
520 $a This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.
650 0 $a Inflammatory bowel diseases $x Molecular diagnosis. $3 3411137
650 0 $a Biochemical markers. $3 587592
650 1 4 $a Gastroenterology. $3 828956
650 2 4 $a Microbial Genetics and Genomics. $3 891163
650 2 4 $a Proteomics. $3 600542
700 1 $a Sheng Ding, Nik. $3 3411136
700 1 $a De Cruz, Peter. $3 664351
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-11446-6
950 $a Medicine (Springer-11650)